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Abstract
Background: Current frequent follow-up after treatment for breast cancer does not meet its intended aims, but does 
depend on expensive and scarce specialized knowledge for routine history taking and physical examinations. The 
study described in this paper compared patient satisfaction with a reduced follow-up strategy, i.e. nurse-led telephone 
follow-up, to satisfaction with traditional hospital follow-up.
Methods: Patient satisfaction was assessed among patients (n = 299) who were participants of a randomized 
controlled trial investigating the cost-effectiveness of several follow-up strategies in the first year after treatment for 
breast cancer. Data on patient satisfaction were collected at baseline, three, six and 12 months after treatment, using 
the Dutch version of Ware's Patient Satisfaction Questionnaire III (PSQ III). In addition to general satisfaction, the PSQ III 
reports on satisfaction scores for technical competence, interpersonal aspects, and access of care. Regression analysis 
was used to predict satisfaction scores from whether or not nurse-led telephone follow-up was received.
Results: Nurse-led telephone follow-up had no statistically significant influence on general patient satisfaction (p = 
0.379), satisfaction with technical competence (p = 0.249), and satisfaction with interpersonal aspects (p = 0.662). 
Regarding access of care, patient satisfaction scores were significantly higher for patients receiving telephone follow-
up (p = 0.015). However, a mean difference at 12 months of 3.1 points was judged to be not clinically relevant.
Conclusions: No meaningful differences were found in satisfaction scores between nurse-led telephone and hospital 
follow-up in the first year after breast cancer treatment. With high satisfaction scores and the potential to substantially 
reduce clinic visits, nurse-led telephone follow-up may be an acceptable alternative to traditional hospital follow-up.
Trial registration number: ISRCTN 74071417.
Background
In most countries, follow-up after curative treatment for
breast cancer consists of frequently scheduled follow-up
visits (2-4 times a year) and an annual routine mammog-
raphy [1]. The main objectives of these visits are the early
detection of a locoregional recurrence or a second pri-
mary breast cancer, detection and registration of side
effects of treatment, and provision of information and
psychological support [1,2]. However, there is much
debate whether these objectives are met in current clini-
cal practice [3,4]. First of all, routine follow-up with clini-
cal examination has been shown not to contribute to
improved survival [5-9]. Additionally, outpatient clinic
visits have been identified as a transition time of high
stress, generating increased anxiety because of the risk of
detecting a recurrence [10]. Also, some studies have sug-
gested that outpatient clinic visits are insufficient to pro-
vide psychological support after breast cancer treatment,
since these visits are often brief and do not include
assessment of psychosocial problems [11]. Hence, current
frequent follow-up visits seem to miss their most impor-
tant goals, but do depend heavily on expensive and scarce
specialized knowledge for routine history taking and
physical examinations. As a result, the improvement in
quality and efficiency of breast cancer follow-up care has
been a government priority setting in many countries
[12,13].
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Alternative strategies for follow-up such as nurse-led
and telephone follow-up have been proposed [14-16]. To
improve healthcare, feedback from patients on these
alternative models of follow-up is essential. Feedback
evaluates the quality of the care provided, and can isolate
problem areas and help generating ideas for further
improvement [17,18]. Moreover, patients may respond
better to treatment and comply better with instructions
when they are satisfied with their care and treatment set-
ting, improving their health outcomes [19-21].
Patient satisfaction with nurse-led follow-up and tele-
phone services was found to be high [22,23], and good
outcomes have been reported in terms of detecting medi-
cal problems and providing support to cancer patients
[24,25]. Recent studies in breast cancer patients have also
shown that telephone follow-up by specialist breast care
nurses (BCNs) was well-received by patients [14,16]. A
randomized clinical trial (RCT) by Beaver and colleagues,
comparing nurse-led telephone follow-up with hospital
follow-up showed that telephone follow-up significantly
improved satisfaction, and it produced no excess anxiety
compared with hospital follow-up [14]. A prospective
cohort study by Montgomery and colleagues showed that
an automated telephone system was easy to use and liked
by most (71%) patients [16].
These studies provided positive results regarding
patient satisfaction for follow-up after breast cancer for
women on average one to two years after diagnosis. How-
ever, there is evidence that most physical and psychologi-
cal recovery is achieved within the first year following
treatment [26]. Therefore, the introduction of nurse-led
telephone follow-up in the first year after treatment may
affect patient satisfaction and quality of care differently
than when applied in a later stage. It is expected that tele-
phone follow-up by a BCN, who is familiar with the
patient, can be appropriate to address psychological con-
sequences after treatment [14]. Moreover, especially in
the first year, telephone follow-up has the potential to
reduce hospital visits.
This paper focused on patient satisfaction with nurse-
led telephone follow-up compared to hospital follow-up
in the first year after breast cancer treatment. Patient sat-
isfaction was measured using a shortened (Dutch) ver-
sion of the validated Patient Satisfaction Questionnaire
(PSQ III) constructed by Ware and colleagues [27]. The
PSQ III measures the multidimensional concept of
patient satisfaction, capturing the most important char-
acteristics of services and providers that might influence
patient satisfaction with care. It is believed to reflect qual-
ity of care and patients' preferences [28].
Methods
Recruitment, design and sample
Patient satisfaction was assessed using data from patients
who were participants of a randomized controlled trial
(RCT) investigating the cost-effectiveness of nurse-led
telephone follow-up after breast cancer (ISRCTN
74071417). A predefined (secondary) aim of the trial was
to compare patient satisfaction between nurse-led tele-
phone and hospital follow-up. Details of the trial design
and protocol execution have been reported previously
[29]. The study was a multicenter randomized trial, with a
2 × 2 factorial design. Between 2005 and 2008, 320
women were recruited through seven hospitals and two
radiotherapy clinics in the South of the Netherlands. Par-
ticipants were eligible for inclusion if they had completed
breast cancer treatment with curative intent less than six
weeks prior to randomization with a WHO performance
score between 0-2, and were fluent in speaking and read-
ing Dutch. Exclusion criteria were distant metastases,
and/or participation in another clinical trial or medical
illness requiring more frequent follow-up. All eligible
patients received detailed study information, including
information about the purpose and effectiveness of breast
cancer follow-up and signs and symptoms of possible
recurrences.
After written informed consent was obtained, partici-
pants were randomly assigned to one of four follow-up
strategies (study arms) during the first 12 months after
treatment; i.e. 1) hospital follow-up every three months,
including mammography at 12 months; 2) nurse-led tele-
phone follow-up every three months, plus hospital visit
and mammography at 12 months; 3) arm 1 plus educa-
tional group program (EGP); 4) arm 2 plus EGP.
Randomization by minimization [30] was performed by
the Comprehensive Cancer Center Limburg using a com-
puterized randomization program (ALEA). Patients were
pre-stratified by hospital and treatment modality (sur-
gery, surgery + radiotherapy, surgery + chemotherapy,
and surgery + radiotherapy + chemotherapy). The study
protocol was approved by the Medical Ethical Review
Board of MAASTRO Clinic (NL). All participating cen-
ters signed a local feasibility declaration, according to
Dutch law and regulations, prior to inclusion of the first
patient.
For the purpose of this analysis, hospital follow-up
(arms 1 and 3) was compared to telephone follow-up
(arms 2 and 4). In total, 162 patients were randomized to
nurse-led telephone follow-up and 158 patients to tradi-
tional hospital follow-up.
Procedures and intervention
In the Netherlands, follow-up after breast cancer in the
first year after treatment consists of routine follow-up
visits to the hospital (i.e. at three, six, nine and 12 months
after treatment) [2]. A mammography is made at 12
months after the start of treatment, which is combined
with a hospital follow-up visit. The provider of follow-up
alternates between the surgeon, BCN, medical oncologist
and radiation oncologist.Kimman et al. BMC Cancer 2010, 10:174
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In patients randomized for hospital follow-up, follow-
up was performed according to the above described
Dutch guidelines. The follow-up visits consisted of physi-
cal examination and medical history and had a scheduled
duration of approximately 10 minutes. In patients ran-
domized for telephone follow-up, follow-up at three, six
and nine months was performed by telephone, by a BCN
or nurse practitioner (NP) working at this hospital, pref-
erably the same nurse at each follow-up moment. At 12
months, a mammography was made and combined with a
hospital follow-up. The telephone follow-up included a
semi-structured interview in which physical -especially
loco-regional- and psychosocial symptoms, treatment
side effects and compliance with hormonal therapy were
discussed. Furthermore, the BCN informed about general
well-being of the patient, her family life, relationships,
and work reintegration. Time scheduled for the telephone
interview was approximately 15-20 minutes. If the patient
had specific complaints or did not feel reassured, an addi-
tional appointment was made for her to come to the hos-
pital. In order to adequately perform the telephone
interview, all participating nurses attained four half-day
training sessions, specifically developed for this study. In
t h i s  t r a i n i n g  BCN s  w e r e  i n f o rm ed  o n  t h e  m os t  r ec e n t
developments in breast cancer treatment and follow-up,
and practiced their telephone communication skills with
a simulation patient. Twenty-one BCNs from seven hos-
pitals were trained.
Outcome measures of effect
To assess patient satisfaction the Dutch version of the val-
idated Ware's Patient Satisfaction Questionnaire III (PSQ
III) was used (see Additional file 1). The PSQ III captures
the most important characteristics of services and pro-
viders that might influence patient satisfaction with care.
The Dutch version has left out financial aspects of the
original questionnaire (i.e. questions 4, 10, 14, 19, 24, 27,
32 and 44), since in the Dutch health care system the per-
sonal financial situation is not directly related to the pro-
vision and quality of medical care. The structure and
reliability of the PSQ III has been tested in a large sample
of cancer patients in the Netherlands who were on aver-
age 8.6 months after treatment. Of this sample 31.1%
were breast cancer patients. The PSQ III appeared an
appropriate measure of cancer patients' satisfaction [27].
The PSQ III is a three factor model: besides general sat-
isfaction (PSQ total), it consists of satisfaction with inter-
personal aspects (IA) of the health care professional (i.e.
providing explanations, listening skills, hasty behavior,
empathy and respect), technical competence (TC) (i.e.
knowledge of latest treatment techniques, competences
of specialist/nurse) and satisfaction with access of care
(AC) (i.e. easy and quick access to care, quality of care,
waiting time). The questionnaire contains 43 favorably
and unfavorably worded statements. Respondents are
asked to indicate their agreement with the statements
with respect to the care they received. The statements in
the questionnaire all assume that medical care is pro-
vided by a doctor. To adjust to the study environment, the
'nurse' was added to the questionnaire. For example, 'the
doctor/nurse who treats me has a genuine interest in me
as a person' (question 17). Items are included in the ques-
tionnaire in random order and the answer alternatives
range from 1 (strongly agree) to 5 (strongly disagree) [27].
Answers to favorably worded statements are reverse-
coded, so that a higher number indicates more satisfac-
tion. Sum scores were calculated for the PSQ total scale
and for the three dimensions and subsequently trans-
formed into a 100-point scale.
Possible response bias was investigated by using the
matched-pairs method [31]. This methods checks
whether a respondent tends to agree (or disagree) with
two statements known to define opposite ends of the
same satisfaction continuum, e.g. 'Doctors/nurses care-
f u l l y  l i s t e n  t o  w h a t  I  h a v e  t o  s a y '  a n d  ' D o c t o r s / n u r s e s
sometimes ignore what I tell them'. The PSQ III includes
five matched pairs. Each of these pairs is assigned a score
of 0 if no response bias is present and 1 if response bias is
present. Consequently, the theoretical range of response
bias is 0 to 5; a score of 0 indicates no response bias,
whereas a score of 2 or higher represents substantial bias.
The PSQ III was filled out before randomization at
baseline, and three, six and 12 months after treatment.
Patients received the questionnaire at home approxi-
mately one week after the follow-up visit or telephone
interview and were asked to return it by mail in an
enclosed envelope.
Protocol compliance
Data on the actual follow-up received, thus number of
hospital visits and telephone contacts with a BCN, were
collected from patient files.
Statistical analysis
The sample size for this study was determined by the
sample size of the RCT, which was based on its primary
outcome measure, i.e. health-related quality of life
(HRQoL) at 12 months after end of treatment [29]. This
paper deals with patient satisfaction at 12 months after
treatment. We hypothesized that satisfaction with nurse-
led telephone follow-up, regarding general satisfaction,
interpersonal aspects, technical competences, and access
of care, could be different from satisfaction with hospital
follow-up. A difference in satisfaction scores of at least
0.5 standard deviation (SD), a medium effect, was consid-
ered to be clinically relevant. Assuming an SD of 17.9 for
both groups [27], post hoc calculations showed that a
sample of 299 patients from the RCT allowed to demon-Kimman et al. BMC Cancer 2010, 10:174
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strate a clinically relevant difference between nurse-led
telephone and hospital follow-up (i.e. 8.95 points differ-
ence) with 90% statistical power and an α of 0.05.
Data were entered in a database by a professional center
for data and information management and analyzed
using SPSS version 17.0. Missing values within the sur-
vey's subscales were replaced using the regression func-
t i o n  i n  S P S S  i f  n o  m o r e  t h a n  h a l f  o f  t h e  i t e m s  w e r e
missing. If more than half of the items were missing the
subscale was considered missing. If three or four PSQ III
questionnaires were not returned, the patient was judged
to be lost to follow-up. Missing data (i.e. subscales) from
one or two questionnaires or missing covariates were
imputed by means of Rubin's multiple imputation proce-
dure [32,33].
Differences in patient characteristics between tele-
phone and hospital follow-up were compared using the
X2 test and independent sample t-test. Regression analy-
ses were used to predict outcome differences by including
or excluding the intervention. Linear mixed models were
fitted with telephone follow-up (yes/no), as a fixed factor,
and patient as random factor. In addition, time since end
of treatment, age, hospital, treatment modality, education
level, and the outcome variable at baseline were brought
into the model. In the primary analysis data were ana-
lyzed according to the intention to treat principle. How-
ever, since protocol violation may bias the results (in
either direction), per protocol analyses including only
patients who properly followed the study protocol were
also performed and reported [34,35].
Results
Patients
Data from 299 patients were available for the purpose of
this analysis. In the RCT, 21 of 320 randomized patients
had dropped out of the trial due to various reasons (e.g.
development of metastases, recurrence, or three or more
missing questionnaires). Data of 149 patients randomized
to hospital follow-up and data of 150 patients random-
ized to telephone follow-up were available for the evalua-
tion of patient satisfaction. Mean sample age was 56 years
(SD = 9.9). Sociodemographic and treatment characteris-
tics as well as baseline satisfaction scores were similar in
the two groups (table 1).
Compliance to the protocol
Ten patients randomized for telephone follow-up pre-
ferred to receive hospital follow-up instead, and case
record forms indicated that 20 patients with telephone
follow-up received only one telephone follow-up contact,
which was considered as protocol violation. Hence, 120 of
the 150 patients in the telephone follow-up group,
received telephone follow-up according to the protocol.
Since hospital follow-up represented usual care, no pro-
tocol violations were apparent in this group.
The 30 patients who violated the protocol in the tele-
phone group did not differ from other patients in this
group regarding age, education, treatment modality and
satisfaction scores at baseline (all p-values > 0.05).
Table 2 shows the mean number of total hospital visits
and telephone contacts with the breast care nurse per
group for the study period of one year. In the hospital
group patients had on average 5.9 visits to the hospital, of
which four visits were conform protocol and 1.9 were
additional visits. In the telephone group patients had on
average 2.4 telephone contacts with the BCN and 3.4 vis-
its to the hospital, of which one hospital visit was con-
form protocol and 2.4 were additional visits.
Patient satisfaction
Since patients who violated the protocol for telephone
follow-up did not differ from patients who adhered to
telephone follow-up, results from the intention to treat
analyses are discussed as the primary outcomes in this
section.
In the first year after treatment patient satisfaction
scores were high in both groups in all subscales of the
PSQ III, at all time points (see figure 1). Table 3 shows
satisfaction scores at 12 months after treatment. General
patient satisfaction at 12 months was 75.3 (SD = 19.6) in
the hospital follow-up group and 76.4 (SD = 19.7) in the
telephone follow-up group. Patient satisfaction regarding
technical competence was 73.7 (SD = 17.9) for the hospi-
tal follow-up group and 75.8 (SD = 16.8) for the telephone
follow-up group. Satisfaction with interpersonal aspects
was 78.7 (SD = 18.5) for the hospital follow-up group and
78.9 (SD = 17.6) for the telephone group. Regarding
access of care satisfaction for the hospital follow-up
group was 73.3 (SD = 15.7) and for the telephone follow-
up group 76.4 (SD = 15.6). Regression analysis showed
that nurse-led telephone follow-up had no statistically
significant influence on general patient satisfaction (p =
0.379), satisfaction with technical competence (p =
0.249), and satisfaction with interpersonal aspects (p =
0.662). Regarding access of care, patient satisfaction was
significantly higher for patients receiving telephone fol-
low-up (p = 0.015). However, a mean difference at 12
months of 3.1 points may be statistically significant, but
was not considered clinically relevant (i.e. < medium
effect).
In the per protocol analyses, ten patients who had
refused telephone follow-up after randomization were
analyzed in the hospital follow-up group, while the 20
patients who had not properly received telephone follow-
up were excluded from the analyses. Per protocol analy-
ses showed almost identical results to intention to treat
analyses (table 3). However, in contrast to the intention toKimman et al. BMC Cancer 2010, 10:174
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Table 1: Sociodemographic and treatment characteristics of participants (n = 299) according to hospital or telephone 
follow-up.
Total group
(n = 299)
Hospital follow-up 
(n = 149)
Telephone follow-up 
(n = 150)
p-value
Age at randomization 
(years)
Mean (SD) 56 (9.9) 56 (10.7) 55 (9.0) 0.50
Range 23-78 23-78 34-75 0.06
< 45 36 (12) 18 (12) 18 (12)
45-64 203 (68) 93 (62) 110 (73)
≥ 65 60 (20) 38 (26) 22 (15)
Level of education 0.36
Low 102 (34) 45 (30) 57 (39)
Middle 118 (40) 62(42) 56 (37)
High 79 (26) 42 (28) 37 (24)
Marital status 0.15
Married 212 (71) 109 (73) 103 (69)
Unmarried 33 (11) 16 (11) 17 (11)
Cohabiting 29 (10) 9 (6) 20 (13)
Widowed 25 (8) 15 (10) 10 (7)
Treatment modality 0.99
Surgery 29 (10) 15 (10) 14 (9)
Surgery + radiotherapy (RT) 178(60) 89 (60) 89 (60)
Surgery + chemotherapy 
(CH)
15 (5) 7 (5) 8 (5)
Surgery + RT + CH 77 (25) 38 (25) 39 (26)
Hormonal therapy 0.59
Yes 94 (31) 50 (34) 44 (29)
No 205 (69) 99 (66) 106 (71)
Baseline satisfaction 
scores (mean (SD)
General satisfaction 77.2 (19.5) 77.7 (14.2) 76.7 (18.9) 0.65
Interpersonal aspects 81.8 (17.5) 81.4 (17.6) 82.2 (17.5) 0.70
Access of care 76.9 (14.0) 77.4 (14.2) 76.4 (13.8) 0.54
Technical competence 77.0 (16.3) 76.7 (17.2) 77.4 (15.4) 0.69
Values are numbers (percentages) unless stated otherwise.Kimman et al. BMC Cancer 2010, 10:174
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treat analysis, higher patient satisfaction scores in the
telephone group regarding access of care were not signifi-
cant (p = 0.060).
Response bias
Response bias in the questionnaire was tested on the 12
months data. We found neglectable response bias scores
for the tendency to disagree regardless of content (0.7% of
respondents), but 14% of respondents showed substantial
response bias, i.e. agreed with two or more (out of five)
opposite statements regardless of their content. Never-
theless, an analysis with a calibrated sample of respon-
dents without response bias (n = 257) showed identical
results to the main analysis regarding all factors of satis-
faction (data not shown).
Discussion
To improve follow-up care after breast cancer, feedback
from patients on satisfaction is important since it pro-
vides information on the quality of care received. Fur-
thermore, patients may comply better with a specific
follow-up strategy when they are satisfied with their care
and follow-up setting. Insight into patient satisfaction
when evaluating telephone follow-up was therefore an
important aspect of our RCT.
The results of this study show that nurse-led telephone
follow-up after breast cancer may well be an appropriate
alternative to hospital follow-up. Patient satisfaction
scores at 12 months after treatment were high in all sub-
scales of the PSQ III for both nurse-led telephone and
hospital follow-up. No meaningful differences were
found between the two types of follow-up in scores for
general satisfaction, satisfaction with interpersonal
aspects, satisfaction with technical competences of staff
and access of care. Since equivalence was seen as a posi-
tive outcome in this study, it was important to carefully
analyze protocol violators and perform both intention to
treat and per protocol analyses [35]. Both types of analy-
ses showed almost identical results. This was expected
since the 30 patients who violated the protocol in the tele-
phone group did not significantly differ from other par-
ticipants in this group regarding age, level of education,
treatment received and baseline satisfaction scores.
To our knowledge, this was the first study to evaluate
the multidimensional concept of patient satisfaction with
nurse-led telephone follow-up specifically aimed at the
first year after breast cancer treatment. It is also one of
the few studies that used a validated questionnaire to
measure patient satisfaction [36]. Although the PSQ III
was not specifically developed to measure satisfaction
with follow-up care and response bias is a documented
problem of the questionnaire, the Dutch version was vali-
dated among breast cancer patients after treatment and
satisfaction and response bias scores found in our study
were similar to the norm scores found by Hagedoorn and
colleagues [27]. Furthermore, the pragmatic nature of the
RCT led to the inclusion of a broad range of patients
regarding age, treatment and location of treatment,
including a sample representative of breast cancer
patients in the Netherlands [37].
Table 2: Number of contacts with medical specialist (MS) and breast care nurse (BCN) according to follow-up group 
(hospital and telephone) in one year.
Hospital follow-up Telephone follow-up
Conform 
protocol
Additional 
contacts
Total 
contacts
Conform 
protocol
Additional 
contacts
Total 
contacts
Intention to 
treat analysis
Visits hospital 
(MS or BCN)
4 1.9 5.9 (2.2) 1 2.4 3.4 (2.4)
Telephone 
contact BCN
0 0.1 0.1 (0.4) 3 -0.6a 2.4 (1.1)
Per protocol 
analysis
Visits hospital 
(MS or BCN)
4 2.9 5.9 (2.2) 1 2.0 3.0 (2.3)
Telephone 
contact BCN
0 0.1 0.1 (0.4) 3 -0.2a 2.8 (0.7)
Numbers are means and standard deviations.
a Negative numbers imply fewer contacts than set by the protocolKimman et al. BMC Cancer 2010, 10:174
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In general, the positive findings in this study were simi-
lar to findings reported in other studies investigating
nurse-led telephone follow-up [14,16,27,38]. Even though
the results are difficult to compare, there is a strong trend
towards acceptability, feasibility and good patient satis-
faction scores for telephone follow-up. The recent study
by Beaver and colleagues is most comparable to our
study. In their randomized clinical trial (n = 374), a struc-
tured telephone intervention was developed and nurses
received four half day training sessions, similar to our
study. Patient satisfaction was evaluated at the beginning,
middle, and end of the trial, by asking participants if they
were satisfied with information received and whether the
appointment had been helpful in dealing with their con-
cerns. It was found that patient satisfaction was signifi-
cantly higher for telephone follow-up compared to
hospital follow-up at the middle and at the end of the
trial. Women were recruited between 0.5 and 106 months
after the end of treatment and remained in the trial for a
mean of 24 months [14]. In our study women entered
immediately after treatment and remained in the trial for
12 months. Thus, the study by Beaver and colleagues and
our study can be seen as complementary; both provide
evidence that telephone follow-up can be appropriate for
patients in different phases after breast cancer treatment
[14].
Several explanations can be hypothesized for the high
satisfaction scores with nurse-led telephone follow-up.
First of all, telephone follow-up was performed by a spe-
cialized breast care nurse, most often a nurse familiar to
the patient from the time of diagnosis and treatment. It
was expected that patients felt comfortable expressing
emotions and concerns to this nurse [11]. The breast care
nurses were also specifically trained to meet information
and psychological needs. The follow-up may take up to
20 minutes and was done by open discussion, offering the
patient the opportunity to discuss issues they were most
concerned with. Furthermore, nurse-led telephone fol-
low-up provided continuity to the patient. In general, the
same nurse provided the telephone follow-up for a
patient, which is different from hospital follow-up where
patients were seen by the medical oncologist, radiation
oncologist, surgeon, or breast care nurse.
Despite positive results, the conclusion that nurse-led
telephone follow-up provides equal satisfaction com-
pared to hospital follow-up must be made carefully, tak-
ing into account several possible limitations of this study.
First, of eligible patients 64% declined participation in the
Figure 1 Average satisfaction scores for hospital follow-up compared to nurse-led telephone follow-up. Figure 1 presents average satisfaction 
scores for general satisfaction, access of care, technical competences and interpersonal aspects, at baseline, three, six and 12 months after treatment, 
for hospital follow-up compared to nurse-led telephone follow-up. Error bars represent 95% confidence intervals.
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randomized trial. This might be due to a lack of knowl-
edge about the purpose and effectiveness of follow-up
[39,40]. Moreover, the fact that patients were informed
about the usual care (hospital follow-up) before partici-
pation may have also negatively influenced the participa-
tion rate, since patients generally have a preference for
what they know best, the so-called 'status quo bias' [41].
Hence, patient education on follow-up will need special
attention in future trials or when implementing tele-
phone follow-up. The relatively low participation rate of
the RCT may have an impact on the generalizabilty of our
results. It specifically influenced this patient satisfaction
study, since patients who chose to participate in the RCT
may have had either no strong preference for a follow-up
strategy, or positive expectations of the interventions.
Thus, patients may have been somewhat uncritical of the
care provided, or prior expectations about follow-up may
have influenced expressed satisfaction [42,43]. In other
words, patients may have expressed satisfaction no mat-
ter what care was provided. It is unclear whether and if
Table 3: Outcome findings by study group adjusted for treatment, hospital, outcome variable at baseline, age, 
educational level and time since treatment.
Mean (SD) 
telephone
follow-up at 12 
months
Mean (SD) 
hospital
follow-up at 12 
months
Estimated 
difference
95% Confidence Interval 
for differencea
p-value
Intention to treat 
analysis
(n = 150) (n = 149)
General satisfaction
Telephone vs. 
hospital f-up
76.4 (19.7) 75.3 (19.6) 1.86 -2.30 to 6.03 0.379
Interpersonal aspects
Telephone vs. 
hospital f-up
80.5 (17.6) 78.7 (18.5) 0.91 -3.18 to 5.00 0.662
Access of care
Telephone vs. 
hospital f-up
76.4 (15.6) 73.3 (15.7) 3.10 .71 to 6.70 0.015
Technical 
competence
Telephone vs. 
hospital f-up
75.8 (16.8) 73.7 (17.9) 2.13 -1.51 to 5.77 0.249
Per protocol 
analysis
(n = 120) (n = 159)
General satisfaction
Telephone vs. 
hospital f-up
76.2 (19.7) 75.7 (19.9) 1.13 -3.14 to 5.39 0.604
Interpersonal aspects
Telephone vs. 
hospital f-up
81.3 (17.5) 79.2 (18.2) 0.55 -3.63 to 4.73 0.796
Access of care
Telephone vs. 
hospital f-up
75.8 (16.1) 74.7 (15.3) 3.10 -0.13 to 6.32 0.060
Technical 
competence
Telephone vs. 
hospital f-up
75.1 (16.7) 74.1 (18.0) 1.76 -1.91 to 5.42 0.347
a Positive differences imply a higher level of satisfaction in the telephone group.Kimman et al. BMC Cancer 2010, 10:174
http://www.biomedcentral.com/1471-2407/10/174
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so, to what extent, the sample selection has influenced
our results. Additionally, patients who had developed a
recurrence or metastatic disease in the study period were
lost to follow-up. Hence, the analysis included a sample of
patients who remained disease-free in the first year after
treatment. It may be speculated that these patients will
generally show high satisfaction scores.
Second, one in five patients randomized to telephone
follow-up did not receive telephone follow-up according
to protocol, which may in itself be seen as evidence that
the two follow-up strategies were not entirely equal in
terms of preference and feasibility. Indeed, ten patients
requested to receive hospital follow-up directly after hav-
ing been randomized for telephone follow-up. However,
most other protocol violations were related to logistic dif-
ficulties or health-related problems (e.g. the patient
needed to visit the hospital for a complaint, but was unin-
tentionally not re-entered in the telephone follow-up).
Moreover, even though hospital follow-up was better
adhered to in the trial and generally preferred before-
hand, per protocol analyses showed high satisfaction
scores for telephone follow-up, equal to patients who fol-
lowed hospital follow-up.
Third, it must be recognized that all patients received
some follow-up in the hospital, also the patients random-
ized to telephone follow-up, which may have contributed
to the fact that no differences between the two forms of
follow-up were found.
Finally, other outcomes besides patient satisfaction are
relevant when exploring alternative follow-up strategies
for breast cancer, such as the effectiveness in terms of
health-related quality of life, emotional functioning, feel-
ings of anxiety and costs. These outcome measures will
be assessed before implementation of telephone follow-
up (paper in preparation).
Conclusion
This study showed that regular telephone contact with a
breast care nurse and a one-year mammography com-
bined with a hospital visit was equal to traditional hospi-
tal follow-up visits, in terms of general satisfaction, and
satisfaction with regard to technical competences of staff,
access of care and interpersonal aspects. It is concluded
that nurse-led telephone follow-up in the first year after
breast cancer treatment may be an appropriate and
acceptable alternative to hospital follow-up.
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